See also this year's filing and all EDGAR filings for this company.
PDF Report 0000944809_2023_OPKO_HEALTH_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.5876271971936236, 'aggregate_val': 1166950000, 'exp_sum': 450973000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 372672000, 'ResearchAndDevelopmentExpense': 73887000, 'remainder_Expenses': 4414000}} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNetofTax'} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000944809, OPKO HEALTH INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 394,525,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,419,371,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 353,363,000 |
| 4 | LiabilitiesCurrent | 213,480,000 |
| 5 | LiabilitiesNoncurrent | 392,131,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 372,672,000 |
| 9 | ResearchAndDevelopmentExpense | 73,887,000 |
| 10 | remainder_Expenses | 720,391,000 |
| 11 | remainder_Revenues | 1,004,196,000 |
| 12 | remainder_NetIncome | -165,268,000 |
| 13 | remainder_ComprehensiveNetIncome | -13,211,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,167,259,000 |
| 1 | Liabilities | 605,611,000 |
| 2 | Expenses | 1,166,950,000 |
| 3 | Revenues | 1,004,196,000 |
| 4 | StockholdersEquity | 1,561,648,000 |
| 5 | NetIncome | -328,022,000 |
| 6 | ComprehensiveNetIncome | -334,627,500 |
| 7 | BaseVar | 2,561,247,500 |
| 8 | EconomicCapitalRatio | 1.70 |
Edgar->Model Mapping
Feature Distribution
Change over Time
